How were Claritas Pharmaceuticals' earnings last quarter?

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) issued its earnings results on Friday, November, 29th. The company reported ($0.40) earnings per share for the quarter.

When did Claritas Pharmaceuticals' stock split?

Claritas Pharmaceuticals's stock reverse split before market open on Friday, July 23rd 2021. The 1-20 reverse split was announced on Friday, July 23rd 2021. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 23rd 2021. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Claritas Pharmaceuticals?

Shares of KALTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:KALTF

Claritas Pharmaceuticals (KALTF) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free KALTF Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 9,705 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart

Get Claritas Pharmaceuticals alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Claritas Pharmaceuticals Stock (OTCMKTS:KALTF)

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

KALTF Stock News Headlines

July 6, 2023 | finance.yahoo.com

DPHAY - Dechra Pharmaceuticals PLC

June 22, 2023 | marketwatch.com

Animal Health Active Pharmaceutical Ingredients Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

June 21, 2023 | finance.yahoo.com

ACXP - Acurx Pharmaceuticals, Inc.

April 27, 2023 | marketwatch.com

Pharmaceutical Lecithin Market Size, Growth, Outlook, Share, Segmentation Analysis, Revenue And Forecast 2031

March 17, 2023 | marketwatch.com

Generic Drugs Market Share, Segmentation and Forecast 2023-2028

February 14, 2023 | marketwatch.com

2023 Pharmaceutical CDMO Services Market Segmentation and Targeting: Strategies for Success Forecast till 2028

February 13, 2023 | marketwatch.com

2023 Mifepristone Market Segmentation and Targeting: Strategies for Success Forecast till 2028

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 19, 2023 | marketwatch.com

Radioimmunotherapy Treatment Market Geographical Segmentation By Forecast Revenue 2023-2028

January 12, 2023 | finance.yahoo.com

Claritas Pharmaceuticals, Inc. (CLAZF)

January 5, 2023 | marketwatch.com

Online Pharmaceuticals Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Data

November 30, 2022 | marketwatch.com

Analgesics Market Global Investor, Latest Trends, Industry Growth, Size, Segmentation, Future Demands, by Regional Forecast to 2028

September 30, 2022 | marketwatch.com

Pharmaceutical Sachet Market In 2022 : Industry Growth, Top Players, Segmentation and Forecast to 2028 with Top Countries Data

September 22, 2022 | finance.yahoo.com

New Claritas Report Reveals that the U.S. Hispanic Population Grew 89% Since 2000 – and Will Exceed 74 Million Consumers by 2028

September 13, 2022 | reuters.com

Claritas Pharmaceuticals Inc

May 11, 2022 | investing.com

Claritas Pharmaceuticals Inc (CLAS)

March 12, 2022 | benzinga.com

Kaya Now Appoints Stormy Simon As A Director Of The Board

February 22, 2022 | finance.yahoo.com

Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing

February 9, 2022 | finance.yahoo.com

Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022

January 26, 2022 | finance.yahoo.com

Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners

January 17, 2022 | finance.yahoo.com

Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns

January 17, 2022 | finance.yahoo.com

Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners

January 12, 2022 | seekingalpha.com

Claritas Pharmaceuticals signs $5M equity financing deal

January 12, 2022 | finance.yahoo.com

Claritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.

December 22, 2021 | finance.yahoo.com

Claritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newborns

December 21, 2021 | finance.yahoo.com

Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease

See More Headlines

Receive KALTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Claritas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/29/2013
Today: 4/20/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:KALTF
Previous Symbol: OTCMKTS:QUEZF
CUSIP: N/A
CIK: N/A
Web: kalytera.co
Phone: (888) 861-2008
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Robert Edward Farrell
Chairman, President & Chief Executive Officer
Victoria Diana Rudman
Chief Financial Officer, Secretary & Treasurer
Nedira Frenkel
Director-Business Development

Key Competitors

View All Competitors

KALTF Stock Analysis - Frequently Asked Questions

How were Claritas Pharmaceuticals' earnings last quarter?: Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) issued its earnings results on Friday, November, 29th. The company reported ($0.40) earnings per share for the quarter.
When did Claritas Pharmaceuticals' stock split?: Claritas Pharmaceuticals's stock reverse split before market open on Friday, July 23rd 2021. The 1-20 reverse split was announced on Friday, July 23rd 2021. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 23rd 2021. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
How do I buy shares of Claritas Pharmaceuticals?: Shares of KALTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KALTF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial